What's in Nippon Kayaku Co., Ltd.'s pipeline?

Nippon Kayaku Co., Ltd. has 5 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 3 in Phase 1.

Which companies overlap with Nippon Kayaku Co., Ltd.'s portfolio?

Top competitors by shared drug class: Eisai Co., Ltd., Jiangsu Alphamab Biopharmaceuticals Co., Ltd, Jiangsu HengRui Medicine Co., Ltd., Ma Fei，MD, Shanghai Hengrui Pharmaceutical Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/nippon-kayaku-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Nippon Kayaku Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nippon Kayaku Co., Ltd. pipeline: 0 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 1 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
NK105	NK105	phase 3	Microtubule inhibitor	Beta-tubulin	Oncology

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Eisai Co., Ltd. · 1 shared drug class
Jiangsu Alphamab Biopharmaceuticals Co., Ltd · 1 shared drug class
Jiangsu HengRui Medicine Co., Ltd. · 1 shared drug class
Ma Fei，MD · 1 shared drug class
Shanghai Hengrui Pharmaceutical Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Nippon Kayaku Co., Ltd.:

Cite this brief

Drug Landscape (2026). Nippon Kayaku Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/nippon-kayaku-co-ltd. Accessed 2026-05-16.